PA
ONC

Parallel Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Parallel Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.6K Sell
342
-9
-3% -$2.65K ﹤0.01% 1734
2026
Q1 		$104K Buy
351
+68
+24% +$22K ﹤0.01% 1560
2025
Q4 		$86K Buy
283
+26
+10% +$8.51K ﹤0.01% 1550
2025
Q3 		$87.6K Buy
257
+12
+5% +$3.64K ﹤0.01% 1489
2025
Q2 		$59.3K Buy
245
+4
+2% +$981 ﹤0.01% 1626
2025
Q1 		$65.6K Buy
241
+32
+15% +$7.48K ﹤0.01% 1485
2024
Q4 		$38.6K Buy
+209
New +$42.7K ﹤0.01% 1790
2022
Q1 		– Sell
-214
Closed -$58K – 3320
2021
Q4 		$58K Buy
214
+7
+3% +$2.36K ﹤0.01% 1247
2021
Q3 		$75K Buy
207
+22
+12% +$7.19K ﹤0.01% 1103
2021
Q2 		$63K Buy
185
+34
+23% +$11.3K ﹤0.01% 1138
2021
Q1 		$53K Buy
151
+16
+12% +$5.3K ﹤0.01% 1160
2020
Q4 		$35K Buy
135
+35
+35% +$9.64K ﹤0.01% 1247
2020
Q3 		$29K Buy
100
+26
+35% +$6.11K ﹤0.01% 1302
2020
Q2 		$13K Sell
74
-112
-60% -$18.2K ﹤0.01% 1618
2020
Q1 		$22K Buy
186
+16
+9% +$2.5K ﹤0.01% 1282
2019
Q4 		$28K Hold
170
– – ﹤0.01% 1259
2019
Q3 		$21K Buy
170
+9
+6% +$1.2K ﹤0.01% 1341
2019
Q2 		$20K Buy
+161
New +$20.4K ﹤0.01% 1296

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parallel Advisors's ONC Position: Q2 2026 in Review

Parallel Advisors reduced its BeOne Medicines Ltd (ONC) stake by 2.6% in Q2 2026, selling an estimated $2.65K and leaving 342 shares worth $97.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

Parallel Advisors first reported a position in ONC in Q2 2019 and has held it in 18 quarters since. The position peaked at $104K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Parallel Advisors held 342 shares of BeOne Medicines Ltd worth $97.6K as of Q2 2026.
  • Parallel Advisors sold 9 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.65K.
  • BeOne Medicines Ltd made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1734 holding.
  • Parallel Advisors first reported a position in BeOne Medicines Ltd in Q2 2019 and has held it in 18 quarters since.
  • Parallel Advisors's BeOne Medicines Ltd position peaked at $104K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.